Neutral
Last updated: 2026-05-21 19:43:54 ET
Earlier this week, Eli Lilly reported detailed late-phase obesity trial results showing long-term weight maintenance with injectable Zepbound and oral...
Picture a drug so popular that, even in markets where a cheaper generic competitor had just launched, it still grew by 10%. That's what happened to El...
The new venture from the Google DeepMind CEO wants to "reimagine" drug discovery with AI.
Eli Lilly (LLY) stock is back in focus after the company reported a very strong Q1, raised its full year revenue and earnings guidance, and released n...
Family said 43-year-old Rhiannon Rodriguez, who died Tuesday, suffered a medical emergency while driving.
Pharma stocks are gaining momentum as obesity drugs, oncology therapies and biotech innovation boost investor optimism.
BOSTON, May 15, 2026--Liberty All-Star® Growth Fund, Inc. April 2026 Monthly Update
Biogen advances Alzheimer's drug diranersen to late-stage trials after a phase II study misses its main goal but shows cognitive and biomarker gains.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE